Your browser doesn't support javascript.
loading
Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing.
Wang, Xiaofei; Kaneko, Keika; Arakawa, Hiromi; Habano, Eri; Omi, Makiko; Nakashima, Eri; Kawachi, Hiroshi; Tonooka, Akiko; Omatsu, Kohei; Nomura, Hidetaka; Yunokawa, Mayu; Kanao, Hiroyuki; Takahashi, Shunji; Nakajima, Takeshi; Ueki, Arisa.
Afiliação
  • Wang X; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kaneko K; Department of Clinical Genetics, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Arakawa H; Department of Clinical Genetics, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Habano E; Department of Clinical Genetics, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Omi M; Department of Gynecology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakashima E; Department of Breast Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kawachi H; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Tonooka A; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Omatsu K; Department of Gynecology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nomura H; Department of Gynecology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yunokawa M; Department of Gynecology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kanao H; Department of Gynecology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takahashi S; Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakajima T; Genomic Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ueki A; Department of Clinical Genetics, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Case Rep Oncol ; 15(2): 792-797, 2022.
Article em En | MEDLINE | ID: mdl-36157696
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article